eli lilly glp 1 drugs Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk Pill Novo Nordisk vs Eli Lilly:

5 BlancoR

Clinical studies have shown GLP-1 receptor agonists may reduce high-sensitivity C-reactive protein (hs-CRP), tumour necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)

And patients want to access these medications at an affordable price point. Many insurers are narrowing eligibility for GLP-1 coverage to high-risk patientstypically those with Type 2 diabetes, or with a BMI over a certain threshold and a weight-related comorbidity (e.g., hypertension, sleep apnea)

These disorders include Alzheimers disease (AD), Parkinsons disease, amyotrophic lateral sclerosis (ALS), and Huntingtons disease

But within hours of her first dose, she said, she found herself on the phone with poison control